Rapid Micro Biosystems, Inc. Class A Common Stock
RPIDRapid Micro Biosystems, Inc. Class A (RPID) specializes in real-time microbiology solutions for the pharmaceutical, biotech, and food industries. The company develops automated systems and reagents to optimize microbial testing processes, improve accuracy, and reduce turnaround times for quality control laboratories. Their technology aims to enhance laboratory efficiency and ensure compliance with industry regulations.
Company News
Rapid Micro Biosystems reported Q3 2025 revenue of $7.8 million, a 3% growth from 2024. The company received a record multi-system order from a Top 20 global biopharma customer and raised its full-year revenue guidance to at least $33.0 million.
Rapid Micro Biosystems (RPID) delivered earnings and revenue surprises of -6.90% and 0.74%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perfo...
RPID earnings call for the period ending June 30, 2022.
